1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Regulation

AliveCor Shows Off Apple Watch EKG Play, Launches Upgrades

The mobile electrocardiogram innovator hopes to expand its system beyond smartphones to the Apple Watch with a new EKG on a wrist band that is under review by FDA. AliveCor also launched new capabilities for its current system, including voice recording to provide more clinical context for mobile heart readouts.

AliveCor Inc. is beginning to tout its new Apple Watch mobile electrocardiogram device in advance of 510(k) clearance while also launching new features on its existing smartphone-linked system.

The Kardia Band is a wrist band that connects to the Apple Watch; it incorporates a thumb-sized single-lead EKG sensor that the wearer can use to collect on-demand heart signal readouts

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation

MedTech Europe’s Bisazza Urges Action As US Tariffs Jeopardize Critical Global Supply Chains

 
• By Amanda Maxwell

The intricate assembly of medical devices, often involving over 1,000 globally sourced components, faces severe disruption due to new US tariffs. These barriers could halt production and devastate small and medium-sized enterprises (SMEs), MedTech Europe’s CEO, Oliver Bisazza, warns in an interview with Medtech Insight.

UK Medtech Regulators Must Ensure Certainty So Businesses Can Plan Their Futures

 
• By Ashley Yeo

With medtech businesses typically managing investment cycles on a three- to five-year basis, local regulatory processes and forward costs of market entry must offer an attractive environment in which companies can plan for growth, says McDermott Will and Emery’s partner and head of healthcare and life sciences, Sharon Lamb. Broad-scale improvements to NICE’s evaluation offerings would similarly enhance the UK’s value to innovators.

First At-Home Cervical Cancer Screening Tool Gets FDA Clearance

 
• By Elizabeth Orr

The US FDA has approved the Teal Wand, the first at-home cervical cancer screening device. Capable of detecting preclinical cancer with 96% accuracy, it will launch in California in June and expand nationwide soon after.